Sterility Testing Market

Sterility Testing Market (Product: Kits and Reagents, Instruments, and Others; and Application: Biopharmaceutical Manufacturing, Medical Device Manufacturing, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031

Sterility Testing Market Outlook 2031

  • The global industry was valued at US$ 1.8 Bn in 2022
  • It is estimated to grow at a CAGR of 6.2% from 2023 to 2031 and reach US$ 3.1 Bn by the end of 2031

Analyst Viewpoint

Rise in prevalence of chronic and infectious diseases among people and increase in demand for sterility kits from the pharmaceutical sector are augmenting the sterility testing market size. Sterility kits can precisely detect the presence of microorganisms on various medical equipment to avoid the spread of infectious diseases. Growth in adoption of rapid sterility testing to provide quick treatments to patients is augmenting the sterility testing industry value.

Leading companies in the market are forming partnerships with companies operating in the pharmaceutical sector and undertaking acquisitions. This strategy allows companies to develop sterility kits according to their requirements and ensure high performance and result accuracy. Furthermore, manufacturers are investing heavily in research and development activities to adopt advanced technologies and launch new testing kits.

Sterility Testing Market

Market Introduction

Sterility testing refers to a set of activities performed to confirm that products are free from microorganisms. The sterility testing method involves passing a quantity of drug product through filters designed to retain microorganisms. It is followed by a rinse to ensure that no drug product remains on the filter, which can inhibit the growth of microorganisms. These testing methods are extensively employed in the pharmaceutical sector to limit the spread of viruses.

Membrane filtration and direct inoculation are two major types of sterility testing. Membrane filtration sterility testing is the regulatory method of choice for filterable pharmaceutical products, whereas in direct inoculation, a small volume of sample is removed aseptically from the sample unit and inoculated directly into a suitable volume of growth medium before incubation. Accurate determination of purity, hygiene maintenance, disinfecting medical devices, and safety of drugs are key advantages of sterility testing.

Rise in Prevalence of Chronic and Infectious Diseases Fostering Sterility Testing Market Dynamics

Poor sanitation, lack of vaccination, or exposure to infected individuals are causing infectious diseases such as flu, tuberculosis, and human immunodeficiency virus. Changes in lifestyles, eating habits, and lack of physical activities are causing chronic diseases among the geriatric population. Sterility testing is a crucial step to prevent the spread of these diseases by ensuring absence of viable microorganisms in drugs, medical equipment, and other medical devices required during treatments. Thus, rise in prevalence of infectious and chronic diseases is augmenting the sterility testing market revenue.

Increase in demand for rapid sterility testing in the pharmaceutical sector is offering lucrative opportunities for market expansion. Rapid sterility testing has shortened incubation times and reduced subjectivity in result analysis. Growth in popularity of rapid drug testing to ensure quick treatments is creating high demand for sterility testing tools.

Surge in Demand for Sterility Kits from Pharmaceutical Sector Augmenting Market Development

Sterility kits are widely utilized in the pharmaceutical sector to assess the purity of drugs, diagnosis kits, and ensure sanitization. The World Health Organization (WHO) sterility testing guidelines are applicable across a wide range of biological medicinal products, such as biotechnology products, vaccines, cell & tissue products, and blood products. Hence, increase in demand for sterility testing kits in the pharmaceutical sector to ensure purity of various products is bolstering the sterility testing market growth.

Increase in adoption of sterile product testing in biopharmaceuticals is driving the demand for sterility testing kits. Adenosine Triphosphate (ATP) bioluminescence is one of the common rapid sterility testing methods for pharmaceuticals that provides accurate results in a short period of time. Furthermore, increase in investments in drug development and clinical trials by pharmaceutical companies is increasing the use of sterility testing tools.

Regional Outlook

As per the latest regional sterility testing market analysis, North America dominated the global landscape in 2022. Early adoption of advanced technologies and establishment of new biopharmaceutical companies in the region are likely to propel the market share in the next few years. Increase in investments in research and development activities in medical technology and life sciences is fueling the sterility testing industry revenue.

Leading companies in the region are introducing new drugs for prevention of infectious diseases. For instance, in March 2022, VBI Vaccines Inc. launched PreHevbrioin in the United States for the prevention of infection caused by all known subtypes of Hepatitis B Virus (HBV) in adults.

Analysis of Key Players in Sterility Testing Industry

Leading companies in the market are implementing advanced business strategies, such as acquisitions and partnerships to increase their presence in global markets. Manufacturers are adopting the latest sterility testing market trends to launch new testing kits with advanced technologies. They are investing in research and development activities to launch new products with high accuracy and provide results in minimum time.

Some of the leading players in the industry include bioMerieux SA, Merck KGaA, Thermo Fisher Scientific, Sartorius AG, Charles River Laboratories International, Inc., Solvias AG, Becton, Dickinson and Company, and Rapid Micro Biosystems, Inc.

These companies are profiled in the sterility testing market report based on various parameters including company overview, business segments, product portfolio, recent developments, business strategies, and financial overview.

Key Developments

  • In October 2023, Sharp, a global leader in commercial pharmaceutical packaging and clinical trial supply services, acquired Berkshire Sterile Manufacturing (BSM), a Massachusetts-based fill finish Contract Development and Manufacturing Organization (CDMO) for clinical and commercial sterile injectable products. The acquisition enables Sharp to offer a fully integrated small-to-medium scale sterile injectable service offering for the biopharmaceutical industry.
  • In April 2023, Oxford Nanopore Technologies plc, a company delivering a new generation of nanopore-based molecular sensing technology, partnered with bioMérieux SA, a world leader in the field of in vitro diagnostics, to improve health outcomes globally by exploring selected opportunities to bring nanopore sequencing to the infectious disease diagnostics market.

Sterility Testing Market Snapshot

Attribute Detail
Market Size in 2022 US$ 1.8 Bn
Market Forecast (Value) in 2031 US$ 3.1 Bn
Growth Rate (CAGR) 6.2%
Forecast Period 2023-2031
Historical Data Available for 2017-2021
Quantitative Tons US$ Bn for Value
Market Analysis It includes segment analysis as well as regional level analysis. Furthermore, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces Analysis, value chain analysis, and key trend analysis.
Competition Landscape
  • Market share analysis by company (2022)
  • Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy and recent developments, and key financials
Format Electronic (PDF) + Excel
Market Segmentation
  • Product
    • Kits and Reagents
    • Instruments
    • Others
  • Application
    • Biopharmaceutical Manufacturing
    • Medical Device Manufacturing
    • Others
  • Test Type
    • Traditional Sterility Tests
      • Membrane Filtration
      • Immersion Test
    • Rapid Sterility Tests
      • Solid Phase Cytometry
      • Flow Cytometry
      • Bioluminescence
      • Nucleic Acid Amplification
      • Immunological Methods
      • Others
Regions Covered
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
Countries Covered
  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Spain
  • Italy
  • Japan
  • China
  • India
  • Australia & New Zealand
  • Brazil
  • Mexico
  • South Africa
  • GCC Countries
Companies Profiled
  • bioMerieux SA
  • Merck KGaA
  • Thermo Fisher Scientific
  • Sartorius AG
  • Charles River Laboratories International, Inc.
  • Solvias AG
  • Becton, Dickinson and Company
  • Rapid Micro Biosystems, Inc.
Customization Scope Available upon request
Pricing Available upon request

Frequently Asked Questions

How big was the global sterility testing market in 2022?

It was valued at US$ 1.8 Bn in 2022

How is the sterility testing sector expected to grow by 2031?

It is projected to register a CAGR of 6.2% from 2023 to 2031

What are the key factors driving the demand for sterility testing?

Rise in prevalence of chronic and infectious diseases and rise in demand for sterility kits from the pharmaceutical sector

Which was the most lucrative region for the sterility testing industry in 2022?

North America was the most lucrative region in 2022

Who are the prominent sterility testing manufacturers?

bioMerieux SA, Merck KGaA, Thermo Fisher Scientific, Sartorius AG, Charles River Laboratories International, Inc., Solvias AG, Becton, Dickinson and Company, and Rapid Micro Biosystems, Inc.

    1. Preface

        1.1. Market Definition and Scope

        1.2. Market Segmentation

        1.3. Key Research Objectives

        1.4. Research Highlights

    2. Assumptions and Research Methodology

    3. Executive Summary: Global Sterility Testing Market

    4. Market Overview

        4.1. Introduction

            4.1.1. Product Definition

            4.1.2. Industry Evolution/Developments

        4.2. Overview

        4.3. Market Dynamics

            4.3.1. Drivers

            4.3.2. Restraints

            4.3.3. Opportunities

        4.4. Global Sterility Testing Market Analysis and Forecast, 2017–2031

    5. Key Insights

        5.1. Pipeline Analysis

        5.2. Key Product/Brand Analysis

        5.3. Key Mergers & Acquisitions

        5.4. COVID-19 Pandemic Impact on Industry

    6. Global Sterility Testing Market Analysis and Forecast, by Product

        6.1. Introduction & Definition

        6.2. Key Findings/Developments

        6.3. Market Value Forecast, by Product, 2017–2031

            6.3.1. Kits and Reagents

            6.3.2. Instruments

            6.3.3. Others

        6.4. Market Attractiveness Analysis, by Product

    7. Global Sterility Testing Market Analysis and Forecast, by Application

        7.1. Introduction & Definition

        7.2. Key Findings/Developments

        7.3. Market Value Forecast, by Application, 2017–2031

            7.3.1. Biopharmaceutical Manufacturing

            7.3.2. Medical Device Manufacturing

            7.3.3. Others

        7.4. Market Attractiveness Analysis, by Application

    8. Global Sterility Testing Market Analysis and Forecast, by Test Type

        8.1. Introduction & Definition

        8.2. Key Findings/Developments

        8.3. Market Value Forecast, by Test Type, 2017–2031

            8.3.1. Traditional Sterility Tests

                8.3.1.1. Membrane Filtration

                8.3.1.2. Immersion Test

            8.3.2. Rapid Sterility Tests

                8.3.2.1. Solid Phase Cytometry

                8.3.2.2. Flow Cytometry

                8.3.2.3. Bioluminescence

                8.3.2.4. Nucleic Acid Amplification

                8.3.2.5. Immunological Methods

                8.3.2.6. Others

        8.4. Market Attractiveness Analysis, by Application

    9. Global Sterility Testing Market Analysis and Forecast, by Region

        9.1. Key Findings

        9.2. Market Value Forecast, by Region, 2017–2031

            9.2.1. North America

            9.2.2. Europe

            9.2.3. Asia Pacific

            9.2.4. Latin America

            9.2.5. Middle East & Africa

        9.3. Market Attractiveness Analysis, by Region

    10. North America Sterility Testing Market Analysis and Forecast

        10.1. Introduction

        10.2. Key Findings

        10.3. Market Value Forecast, by Product, 2017–2031

            10.3.1. Kits and Reagents

            10.3.2. Instruments

            10.3.3. Others

        10.4. Market Value Forecast, by Application, 2017–2031

            10.4.1. Biopharmaceutical Manufacturing

            10.4.2. Medical Device Manufacturing

            10.4.3. Others

        10.5. Market Value Forecast, by Test Type, 2017–2031

            10.5.1. Traditional Sterility Tests

                10.5.1.1. Membrane Filtration

                10.5.1.2. Immersion Test

            10.5.2. Rapid Sterility Tests

                10.5.2.1. Solid Phase Cytometry

                10.5.2.2. Flow Cytometry

                10.5.2.3. Bioluminescence

                10.5.2.4. Nucleic Acid Amplification

                10.5.2.5. Immunological Methods

                10.5.2.6. Others

        10.6. Market Value Forecast, by Country, 2017–2031

            10.6.1. U.S.

            10.6.2. Canada

        10.7. Market Attractiveness Analysis

            10.7.1. By Product

            10.7.2. By Application

            10.7.3. By Test Type

            10.7.4. By Country

    11. Europe Sterility Testing Market Analysis and Forecast

        11.1. Introduction

        11.2. Key Findings

        11.3. Market Value Forecast, by Product, 2017–2031

            11.3.1. Kits and Reagents

            11.3.2. Instruments

            11.3.3. Others

        11.4. Market Value Forecast, by Application, 2017–2031

            11.4.1. Biopharmaceutical Manufacturing

            11.4.2. Medical Device Manufacturing

            11.4.3. Others

        11.5. Market Value Forecast, by Test Type, 2017–2031

            11.5.1. Traditional Sterility Tests

                11.5.1.1. Membrane Filtration

                11.5.1.2. Immersion Test

            11.5.2. Rapid Sterility Tests

                11.5.2.1. Solid Phase Cytometry

                11.5.2.2. Flow Cytometry

                11.5.2.3. Bioluminescence

                11.5.2.4. Nucleic Acid Amplification

                11.5.2.5. Immunological Methods

                11.5.2.6. Others

        11.6. Market Value Forecast, by Country/Sub-region, 2017–2031

            11.6.1. Germany

            11.6.2. U.K.

            11.6.3. France

            11.6.4. Italy

            11.6.5. Spain

            11.6.6. Rest of Europe

        11.7. Market Attractiveness Analysis

            11.7.1. By Product

            11.7.2. By Application

            11.7.3. By Test Type

            11.7.4. By Country/Sub-region

    12. Asia Pacific Sterility Testing Market Analysis and Forecast

        12.1. Introduction

        12.2. Key Findings

        12.3. Market Value Forecast, by Product, 2017–2031

            12.3.1. Kits and Reagents

            12.3.2. Instruments

            12.3.3. Others

        12.4. Market Value Forecast, by Application, 2017–2031

            12.4.1. Biopharmaceutical Manufacturing

            12.4.2. Medical Device Manufacturing

            12.4.3. Others

        12.5. Market Value Forecast, by Test Type, 2017–2031

            12.5.1. Traditional Sterility Tests

                12.5.1.1. Membrane Filtration

                12.5.1.2. Immersion Test

            12.5.2. Rapid Sterility Tests

                12.5.2.1. Solid Phase Cytometry

                12.5.2.2. Flow Cytometry

                12.5.2.3. Bioluminescence

                12.5.2.4. Nucleic Acid Amplification

                12.5.2.5. Immunological Methods

                12.5.2.6. Others

        12.6. Market Value Forecast, by Country/Sub-region, 2017–2031

            12.6.1. China

            12.6.2. Japan

            12.6.3. India

            12.6.4. Australia & New Zealand

            12.6.5. Rest of Asia Pacific

        12.7. Market Attractiveness Analysis

            12.7.1. By Product

            12.7.2. By Application

            12.7.3. By Test Type

            12.7.4. By Country/Sub-region

    13. Latin America Sterility Testing Market Analysis and Forecast

        13.1. Introduction

        13.2. Key Findings

        13.3. Market Value Forecast, by Product, 2017–2031

            13.3.1. Kits and Reagents

            13.3.2. Instruments

            13.3.3. Others

        13.4. Market Value Forecast, by Application, 2017–2031

            13.4.1. Biopharmaceutical Manufacturing

            13.4.2. Medical Device Manufacturing

            13.4.3. Others

        13.5. Market Value Forecast, by Test Type, 2017–2031

            13.5.1. Traditional Sterility Tests

                13.5.1.1. Membrane Filtration

                13.5.1.2. Immersion Test

            13.5.2. Rapid Sterility Tests

                13.5.2.1. Solid Phase Cytometry

                13.5.2.2. Flow Cytometry

                13.5.2.3. Bioluminescence

                13.5.2.4. Nucleic Acid Amplification

                13.5.2.5. Immunological Methods

                13.5.2.6. Others

        13.6. Market Value Forecast, by Country/Sub-region, 2017–2031

            13.6.1. Brazil

            13.6.2. Mexico

            13.6.3. Rest of Latin America

        13.7. Market Attractiveness Analysis

            13.7.1. By Product

            13.7.2. By Application

            13.7.3. By Test Type

            13.7.4. By Country/Sub-region

    14. Middle East & Africa Sterility Testing Market Analysis and Forecast

        14.1. Introduction

        14.2. Key Findings

        14.3. Market Value Forecast, by Product, 2017–2031

            14.3.1. Kits and Reagents

            14.3.2. Instruments

            14.3.3. Others

        14.4. Market Value Forecast, by Application, 2017–2031

            14.4.1. Biopharmaceutical Manufacturing

            14.4.2. Medical Device Manufacturing

            14.4.3. Others

        14.5. Market Value Forecast, by Test Type, 2017–2031

            14.5.1. Traditional Sterility Tests

                14.5.1.1. Membrane Filtration

                14.5.1.2. Immersion Test

            14.5.2. Rapid Sterility Tests

                14.5.2.1. Solid Phase Cytometry

                14.5.2.2. Flow Cytometry

                14.5.2.3. Bioluminescence

                14.5.2.4. Nucleic Acid Amplification

                14.5.2.5. Immunological Methods

                14.5.2.6. Others

        14.6. Market Value Forecast, by Country/Sub-region, 2017–2031

            14.6.1. GCC Countries

            14.6.2. South Africa

            14.6.3. Rest of Middle East & Africa

        14.7. Market Attractiveness Analysis

            14.7.1. By Product

            14.7.2. By Application

            14.7.3. By Test Type

            14.7.4. By Country/Sub-region

    15. Competition Landscape

        15.1. Market Player - Competitive Matrix (by Tier and Size of Companies)

        15.2. Market Share Analysis, by Company (2022)

        15.3. Company Profiles

            15.3.1. bioMerieux SA

                15.3.1.1. Company Overview

                15.3.1.2. Product Portfolio

                15.3.1.3. SWOT Analysis

                15.3.1.4. Financial Overview

                15.3.1.5. Strategic Overview

            15.3.2. Merck KGaA

                15.3.2.1. Company Overview

                15.3.2.2. Product Portfolio

                15.3.2.3. SWOT Analysis

                15.3.2.4. Financial Overview

                15.3.2.5. Strategic Overview

            15.3.3. Thermo Fisher Scientific

                15.3.3.1. Company Overview

                15.3.3.2. Product Portfolio

                15.3.3.3. SWOT Analysis

                15.3.3.4. Financial Overview

                15.3.3.5. Strategic Overview

            15.3.4. Sartorius AG

                15.3.4.1. Company Overview

                15.3.4.2. Product Portfolio

                15.3.4.3. SWOT Analysis

                15.3.4.4. Financial Overview

                15.3.4.5. Strategic Overview

            15.3.5. Charles River Laboratories International, Inc.

                15.3.5.1. Company Overview

                15.3.5.2. Product Portfolio

                15.3.5.3. SWOT Analysis

                15.3.5.4. Financial Overview

                15.3.5.5. Strategic Overview

            15.3.6. Solvias AG

                15.3.6.1. Company Overview

                15.3.6.2. Product Portfolio

                15.3.6.3. SWOT Analysis

                15.3.6.4. Financial Overview

                15.3.6.5. Strategic Overview

            15.3.7. Becton, Dickinson and Company

                15.3.7.1. Company Overview

                15.3.7.2. Product Portfolio

                15.3.7.3. SWOT Analysis

                15.3.7.4. Financial Overview

                15.3.7.5. Strategic Overview

            15.3.8. Rapid Micro Biosystems, Inc.

                15.3.8.1. Company Overview

                15.3.8.2. Product Portfolio

                15.3.8.3. SWOT Analysis

                15.3.8.4. Financial Overview

                15.3.8.5. Strategic Overview

    List of Tables

    Table 01: Global Sterility Testing Market Size (US$ Mn) Forecast, by Product, 2017–2031

    Table 02: Global Sterility Testing Market Size (US$ Mn) Forecast, by Application, 2017–2031

    Table 03: Global Sterility Testing Market Size (US$ Mn) Forecast, by Test Type, 2017–2031

    Table 04: Global Sterility Testing Market Size (US$ Mn) Forecast, by Region, 2017–2031

    Table 05: North America Sterility Testing Market Size (US$ Mn) Forecast, by Country, 2017–2031

    Table 06: North America Sterility Testing Market Size (US$ Mn) Forecast, by Product, 2017–2031

    Table 07: North America Sterility Testing Market Size (US$ Mn) Forecast, by Application, 2017–2031

    Table 08: North America Sterility Testing Market Size (US$ Mn) Forecast, by Test Type, 2017–2031

    Table 09: Europe Sterility Testing Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 10: Europe Sterility Testing Market Size (US$ Mn) Forecast, by Product, 2017–2031

    Table 11: Europe Sterility Testing Market Size (US$ Mn) Forecast, by Application, 2017–2031

    Table 12: Europe Sterility Testing Market Size (US$ Mn) Forecast, by Test Type, 2017–2031

    Table 13: Asia Pacific Sterility Testing Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 14: Asia Pacific Sterility Testing Market Size (US$ Mn) Forecast, by Product, 2017–2031

    Table 15: Asia Pacific Sterility Testing Market Size (US$ Mn) Forecast, by Application, 2017–2031

    Table 16: Asia Pacific Sterility Testing Market Size (US$ Mn) Forecast, by Test Type, 2017–2031

    Table 17: Latin America Sterility Testing Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 18: Latin America Sterility Testing Market Size (US$ Mn) Forecast, by Product, 2017–2031

    Table 19: Latin America Sterility Testing Market Size (US$ Mn) Forecast, by Application, 2017–2031

    Table 20: Latin America Sterility Testing Market Size (US$ Mn) Forecast, by Test Type, 2017–2031

    Table 21: Middle East & Africa Sterility Testing Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 22: Middle East & Africa Sterility Testing Market Size (US$ Mn) Forecast, by Product, 2017–2031

    Table 23: Middle East & Africa Sterility Testing Market Size (US$ Mn) Forecast, by Application, 2017–2031

    Table 24: Middle East & Africa Sterility Testing Market Size (US$ Mn) Forecast, by Test Type, 2017–2031

    List of Figures

    Figure 01: Global Sterility Testing Market Size (US$ Mn) and Distribution (%), by Region, 2022 and 2031

    Figure 02: Global Sterility Testing Market Revenue (US$ Mn), by Product, 2022

    Figure 03: Global Sterility Testing Market Value Share, by Product, 2022

    Figure 04: Global Sterility Testing Market Revenue (US$ Mn), by Application, 2022

    Figure 05: Global Sterility Testing Market Value Share, by Application, 2022

    Figure 06: Global Sterility Testing Market Revenue (US$ Mn), by Test Type, 2022

    Figure 07: Global Sterility Testing Market Value Share, by Test Type, 2022

    Figure 08: Global Sterility Testing Market Value Share, by Region, 2022

    Figure 09: Global Sterility Testing Market Value (US$ Mn) Forecast, 2017–2031

    Figure 10: Global Sterility Testing Market Value Share Analysis, by Product, 2022 and 2031

    Figure 11: Global Sterility Testing Market Attractiveness Analysis, by Product, 2023-2031

    Figure 12: Global Sterility Testing Market Value Share Analysis, by Application, 2022 and 2031

    Figure 13: Global Sterility Testing Market Attractiveness Analysis, by Application, 2023-2031

    Figure 14: Global Sterility Testing Market Value Share Analysis, by Test Type, 2022 and 2031

    Figure 15: Global Sterility Testing Market Attractiveness Analysis, by Test Type, 2023-2031

    Figure 16: Global Sterility Testing Market Value Share Analysis, by Region, 2022 and 2031

    Figure 17: Global Sterility Testing Market Attractiveness Analysis, by Region, 2023-2031

    Figure 18: North America Sterility Testing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

    Figure 19: North America Sterility Testing Market Attractiveness Analysis, by Country, 2023–2031

    Figure 20: North America Sterility Testing Market Value Share Analysis, by Country, 2022 and 2031

    Figure 21: North America Sterility Testing Market Value Share Analysis, by Product, 2022 and 2031

    Figure 22: North America Sterility Testing Market Value Share Analysis, by Application, 2022 and 2031

    Figure 23: North America Sterility Testing Market Value Share Analysis, by Test Type, 2022 and 2031

    Figure 24: North America Sterility Testing Market Attractiveness Analysis, by Product, 2023–2031

    Figure 25: North America Sterility Testing Market Attractiveness Analysis, by Application, 2023–2031

    Figure 26:North America Sterility Testing Market Attractiveness Analysis, by Test Type, 2023–2031

    Figure 27: Europe Sterility Testing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

    Figure 28: Europe Sterility Testing Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

    Figure 29: Europe Sterility Testing Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

    Figure 30: Europe Sterility Testing Market Value Share Analysis, by Product, 2022 and 2031

    Figure 31: Europe Sterility Testing Market Value Share Analysis, by Application, 2022 and 2031

    Figure 32: Europe Sterility Testing Market Value Share Analysis, by Test Type, 2022 and 2031

    Figure 33: Europe Sterility Testing Market Attractiveness Analysis, by Product, 2023–2031

    Figure 34: Europe Sterility Testing Market Attractiveness Analysis, by Application, 2023–2031

    Figure 35: Europe Sterility Testing Market Attractiveness Analysis, by Test Type, 2023–2031

    Figure 36: Asia Pacific Sterility Testing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

    Figure 37: Asia Pacific Sterility Testing Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

    Figure 38: Asia Pacific Sterility Testing Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

    Figure 39: Asia Pacific Sterility Testing Market Value Share Analysis, by Product, 2022 and 2031

    Figure 40: Asia Pacific Sterility Testing Market Value Share Analysis, by Application, 2022 and 2031

    Figure 41: Asia Pacific Sterility Testing Market Value Share Analysis, by Test Type, 2022 and 2031

    Figure 42: Asia Pacific Sterility Testing Market Attractiveness Analysis, by Product, 2023–2031

    Figure 43: Asia Pacific Sterility Testing Market Attractiveness Analysis, by Application, 2023–2031

    Figure 44: Asia Pacific Sterility Testing Market Attractiveness Analysis, by Test Type, 2023–2031

    Figure 45: Latin America Sterility Testing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

    Figure 46: Latin America Sterility Testing Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

    Figure 47: Latin America Sterility Testing Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

    Figure 48: Latin America Sterility Testing Market Value Share Analysis, by Product, 2022 and 2031

    Figure 49: Latin America Sterility Testing Market Value Share Analysis, by Application, 2022 and 2031

    Figure 50: Latin America Sterility Testing Market Value Share Analysis, by Test Type, 2022 and 2031

    Figure 51: Latin America Sterility Testing Market Attractiveness Analysis, by Product, 2023–2031

    Figure 52: Latin America Sterility Testing Market Attractiveness Analysis, by Application, 2023–2031

    Figure 53: Latin America Sterility Testing Market Attractiveness Analysis, by Test Type, 2023–2031

    Figure 54: Middle East & Africa Sterility Testing Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

    Figure 55: Middle East & Africa Sterility Testing Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

    Figure 56: Middle East & Africa Sterility Testing Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

    Figure 57: Middle East & Africa Sterility Testing Market Value Share Analysis, by Product, 2022 and 2031

    Figure 58: Middle East & Africa Sterility Testing Market Value Share Analysis, by Application, 2022 and 2031

    Figure 59: Middle East & Africa Sterility Testing Market Value Share Analysis, by Test Type, 2022 and 2031

    Figure 60: Middle East & Africa Sterility Testing Market Attractiveness Analysis, by Product, 2023–2031

    Figure 61: Middle East & Africa Sterility Testing Market Attractiveness Analysis, by Application, 2023–2031

    Figure 62: Middle East & Africa Sterility Testing Market Attractiveness Analysis, by Test Type, 2023–2031

Copyright © Transparency Market Research, Inc. All Rights reserved